| Sarah Sheikh, MD | |
|
750 Brunswick Ave, Trenton, NJ 08638-4143 | |
| (609) 394-6000 | |
| Not Available |
| Full Name | Sarah Sheikh |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 25 Years |
| Location | 750 Brunswick Ave, Trenton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194139576 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 25MA11355100 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of New Jersey Omb Centralized Payroll | 6406742592 | 81 |
News Archive
The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a $5 million grant to researchers at University of California San Diego School of Medicine to conduct a first-in-human Phase 1 clinical trial of a gene therapy for treating Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.
Titan Pharmaceuticals, Inc. today announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid addiction, and the study is expected to complete enrollment by early fourth quarter of this year, which is almost three months ahead of schedule.
Satellite images, air quality measurements and smoke forecasting models are useful tools to help individuals and public health professionals prepare for smoke episodes in areas at risk from forest fire smoke, according to University of British Columbia researcher Michael Brauer.
Not all Latinos face the same health challenges, suggesting that public health approaches may need to be tailored based on needs of the diverse groups within the Latino population, new research from Oregon State University indicates.
Every year as many as seven million adults in the United States experience delirium during hospitalization. In a systematic review of the scientific literature on delirium prevention and treatment, investigators from the Regenstrief Institute, Indiana University, and Wishard Health Services found that despite the significant health and financial burdens of delirium for hospitalized adults, no effective way to prevent or treat the condition has been identified.
› Verified 4 days ago
| Entity Name | State Of New Jersey Omb Centralized Payroll |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336221878 PECOS PAC ID: 6406742592 Enrollment ID: O20040420000292 |
News Archive
The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a $5 million grant to researchers at University of California San Diego School of Medicine to conduct a first-in-human Phase 1 clinical trial of a gene therapy for treating Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.
Titan Pharmaceuticals, Inc. today announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid addiction, and the study is expected to complete enrollment by early fourth quarter of this year, which is almost three months ahead of schedule.
Satellite images, air quality measurements and smoke forecasting models are useful tools to help individuals and public health professionals prepare for smoke episodes in areas at risk from forest fire smoke, according to University of British Columbia researcher Michael Brauer.
Not all Latinos face the same health challenges, suggesting that public health approaches may need to be tailored based on needs of the diverse groups within the Latino population, new research from Oregon State University indicates.
Every year as many as seven million adults in the United States experience delirium during hospitalization. In a systematic review of the scientific literature on delirium prevention and treatment, investigators from the Regenstrief Institute, Indiana University, and Wishard Health Services found that despite the significant health and financial burdens of delirium for hospitalized adults, no effective way to prevent or treat the condition has been identified.
› Verified 4 days ago
| Entity Name | Capital Health Multispecialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083072342 PECOS PAC ID: 1850689894 Enrollment ID: O20161007000162 |
News Archive
The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a $5 million grant to researchers at University of California San Diego School of Medicine to conduct a first-in-human Phase 1 clinical trial of a gene therapy for treating Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.
Titan Pharmaceuticals, Inc. today announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid addiction, and the study is expected to complete enrollment by early fourth quarter of this year, which is almost three months ahead of schedule.
Satellite images, air quality measurements and smoke forecasting models are useful tools to help individuals and public health professionals prepare for smoke episodes in areas at risk from forest fire smoke, according to University of British Columbia researcher Michael Brauer.
Not all Latinos face the same health challenges, suggesting that public health approaches may need to be tailored based on needs of the diverse groups within the Latino population, new research from Oregon State University indicates.
Every year as many as seven million adults in the United States experience delirium during hospitalization. In a systematic review of the scientific literature on delirium prevention and treatment, investigators from the Regenstrief Institute, Indiana University, and Wishard Health Services found that despite the significant health and financial burdens of delirium for hospitalized adults, no effective way to prevent or treat the condition has been identified.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Sheikh, MD 23 Exeter Rd, Jersey City, NJ 07305-1209 Ph: (201) 259-4185 | Sarah Sheikh, MD 750 Brunswick Ave, Trenton, NJ 08638-4143 Ph: (609) 394-6000 |
News Archive
The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a $5 million grant to researchers at University of California San Diego School of Medicine to conduct a first-in-human Phase 1 clinical trial of a gene therapy for treating Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.
Titan Pharmaceuticals, Inc. today announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid addiction, and the study is expected to complete enrollment by early fourth quarter of this year, which is almost three months ahead of schedule.
Satellite images, air quality measurements and smoke forecasting models are useful tools to help individuals and public health professionals prepare for smoke episodes in areas at risk from forest fire smoke, according to University of British Columbia researcher Michael Brauer.
Not all Latinos face the same health challenges, suggesting that public health approaches may need to be tailored based on needs of the diverse groups within the Latino population, new research from Oregon State University indicates.
Every year as many as seven million adults in the United States experience delirium during hospitalization. In a systematic review of the scientific literature on delirium prevention and treatment, investigators from the Regenstrief Institute, Indiana University, and Wishard Health Services found that despite the significant health and financial burdens of delirium for hospitalized adults, no effective way to prevent or treat the condition has been identified.
› Verified 4 days ago
Audrey Whilma Henry, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1 Capital Way, Psychiatry Dept, Trenton, NJ 08638 Phone: 609-394-6085 Fax: 609-394-6250 | |
Dr. Lawrence Nicholas Rossi, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 101 Sullivan Way, Trenton Psychiatric Hospital, Trenton, NJ 08628 Phone: 609-633-1562 Fax: 609-633-8527 | |
Mohammad M Bari, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 609-394-6000 | |
Dr. Erica Lynn Musser, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Bates Building 2nd Floor Whittlesey Road, Uchc C/o Njdoc, Trenton, NJ 08625 Phone: 856-459-7000 Fax: 856-459-8713 | |
John Wilkins, DO Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 609-394-6000 | |
Dr. Robert Paul Eilers, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 222 S. Warren Street, Trenton, NJ 08625 Phone: 609-777-0686 |